These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33341519)

  • 1. Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.
    Zdanyte M; Wrazidlo RW; Kaltenbach S; Groga-Bada P; Gawaz M; Geisler T; Rath D
    Atherosclerosis; 2021 Feb; 318():1-7. PubMed ID: 33341519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive value of the GRACE discharge score on the long-term out-of-hospital coronary thrombotic events after implantation of drug-eluting stents].
    Zhao XY; Li JX; Tang XF; Xian Y; Xu JJ; Song Y; Jiang L; Xu LJ; Chen J; Zhang Y; Song L; Gao LJ; Gao Z; Zhang J; Wu Y; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):187-191. PubMed ID: 29562422
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations.
    Song L; Guan C; Yan H; Qiao S; Wu Y; Yuan J; Dou K; Yang Y; Dangas GD; Xu B
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):573-581. PubMed ID: 29322612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.
    Jakimov T; Mrdović I; Filipović B; Zdravković M; Djoković A; Hinić S; Milić N; Filipović B
    Croat Med J; 2017 Dec; 58(6):406-415. PubMed ID: 29308832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor.
    Bianco M; D'ascenzo F; Raposeiras Roubin S; Kinnaird T; Peyracchia M; Ariza-Solé A; Cerrato E; Manzano-Fernández S; Gravinese C; Templin C; Destefanis P; Velicki L; Luciano A; Xanthopoulou I; Rinaldi M; Rognoni A; Varbella F; Boccuzzi G; Omedè P; Montabone A; Bernardi A; Taha S; Rossini R; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Giustetto C; Garay A; Quadri G; Queija BC; Srdanovic I; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Lopez-Cuenca Á; Cequier A; Alexopoulos D; Iñiguez-Romo A; Pozzi R; Assi EA; Valgimigli M
    Int J Cardiol; 2020 Feb; 301():200-206. PubMed ID: 31785951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.
    Marquis-Gravel G; Neely ML; Valgimigli M; Costa F; Van Klaveren D; Altner R; Bhatt DL; Armstrong PW; Fox KAA; White HD; Ohman EM; Roe MT
    Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006582. PubMed ID: 32862694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients.
    Abu-Assi E; Raposeiras-Roubin S; Cobas-Paz R; Caneiro-Queija B; Martínez-Reglero C; Rodríguez-Rodríguez JM; Baz A; Íñiguez-Romo A
    EuroIntervention; 2018 Mar; 13(16):1914-1922. PubMed ID: 29131804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Chen Y; Yin T; Xi S; Zhang S; Yan H; Tang Y; Qian J; Chen J; Su X; Du Z; Wang L; Qin Q; Gao C; Zheng Y; Zhao X; Cheng X; Li Z; Zhang W; Chen H; Wang J; Yang Z; Li H; Liu H; Zhou X; Qu B; Xiang D; Guo Y; Wang L; Nie S; Fu G; Yang M; Cai S
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1194-1204. PubMed ID: 31112635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
    Tomaniak M; Chichareon P; Klimczak-Tomaniak D; Takahashi K; Kogame N; Modolo R; Wang R; Ono M; Hara H; Gao C; Kawashima H; Rademaker-Havinga T; Garg S; Curzen N; Haude M; Kochman J; Gori T; Montalescot G; Angiolillo DJ; Capodanno D; Storey RF; Hamm C; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW; Anderson R
    Clin Res Cardiol; 2020 Jul; 109(7):930-943. PubMed ID: 31925529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events.
    Kawashima H; Gao C; Takahashi K; Tomaniak M; Ono M; Hara H; Wang R; Chichareon P; Suryapranata H; Walsh S; Cotton J; Koning R; Rensing B; Wykrzykowska J; de Winter RJ; Garg S; Anderson R; Hamm C; Steg PG; Onuma Y; Serruys PW
    Thromb Haemost; 2020 Jul; 120(7):1087-1095. PubMed ID: 32572864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaemia to predict outcome in patients with acute coronary syndromes.
    Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
    Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores.
    Montalto C; Crimi G; Morici N; Piatti L; Grosseto D; Sganzerla P; Tortorella G; De Rosa R; De Luca L; De Luca G; Palmerini T; Valgimigli M; Savonitto S; De Servi S
    Int J Cardiol; 2021 Apr; 328():22-28. PubMed ID: 33279593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.
    Choi KH; Song YB; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2020 May; 13(5):e008530. PubMed ID: 32354228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and PARIS risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention.
    Yoshida R; Ishii H; Morishima I; Tanaka A; Morita Y; Takagi K; Yoshioka N; Hirayama K; Iwakawa N; Tashiro H; Kojima H; Mitsuda T; Hitora Y; Furusawa K; Tsuboi H; Murohara T
    J Cardiol; 2019 Jun; 73(6):479-487. PubMed ID: 30598387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study.
    Li J; Li Y; Qiu M; Li Z; Yang J; Wang X; Bao D; Wang X; Han Y
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():579-586. PubMed ID: 31872515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving risk stratification in non-ST-segment elevation myocardial infarction with combined assessment of GRACE and CRUSADE risk scores.
    Paiva L; Providência R; Barra SN; Dinis P; Faustino AC; Costa M; Gonçalves L
    Arch Cardiovasc Dis; 2014 Dec; 107(12):681-9. PubMed ID: 25219759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI.
    Chichareon P; Modolo R; Kawashima H; Takahashi K; Kogame N; Chang CC; Tomaniak M; Ono M; Walsh S; Suryapranata H; Cotton J; Koning R; Akin I; Kukreja N; Wykrzykowska J; Piek JJ; Garg S; Hamm C; Steg PG; Jüni P; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2020 Mar; 13(5):634-646. PubMed ID: 32139222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CADILLAC and GRACE risk scores on short- and long-term clinical outcomes in patients with acute myocardial infarction.
    Sato T; Saito Y; Matsumoto T; Yamashita D; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    J Cardiol; 2021 Sep; 78(3):201-205. PubMed ID: 33947628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of PARIS and CREDO-Kyoto Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients With Acute Myocardial Infarction.
    Yamashita D; Saito Y; Sato T; Matsumoto T; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    Circ J; 2022 Mar; 86(4):622-629. PubMed ID: 34588393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial.
    Gargiulo G; Ariotti S; Santucci A; Piccolo R; Baldo A; Franzone A; Magnani G; Marino M; Esposito G; Windecker S; Valgimigli M
    JACC Cardiovasc Interv; 2016 Sep; 9(17):1780-9. PubMed ID: 27544007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.